Clinical trial

AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

NCT05840016

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-08-17

PhasePHASE3

Study timeline

Study start (actual)2023-08-17Date precision: day

Registry last updated2025-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Squamous Non Small Cell Lung Cancerunresolved

Interventions

AK112, Carboplatin, PaxlitaxelDRUG

Tislelizumab, Carboplatin, PaxlitaxelDRUG

Sponsors & collaborators

Akesolead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05840016 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.